Biofrontera (BFRI) Invested Capital (2021 - 2024)

Biofrontera's Invested Capital history runs 4 years deep, the most recent figure standing at $296000.0 for Q2 2024.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $296000.0 in Q2 2024; TTM through Mar 2025 was $296000.0, a 96.28% decrease from a year earlier, with the FY2023 full-year figure at $3.9 million, down 43.76% from the prior year.
• Invested Capital slipped to $296000.0 in Q2 2024 per BFRI's latest filing, from $2.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $7.0 million in Q1 2023 and bottomed at $296000.0 in Q2 2024.
• The 4-year median for Invested Capital is $3.2 million (2021), against an average of $3.6 million.
• Across the five-year window, Invested Capital surged 114.13% in 2022 and tumbled 66.51% in 2024, its largest moves.
• Year by year, Invested Capital stood at $3.2 million in 2021, then soared by 114.13% to $6.9 million in 2022, then sank by 43.76% to $3.9 million in 2023, then sank by 92.42% to $296000.0 in 2024.
• Per Business Quant, the three latest BFRI Invested Capital figures stand at $296000.0 (Q2 2024), $2.4 million (Q1 2024), and $3.9 million (Q4 2023).